Sarena Francis Willard
Insider CIK 1423786 · FPRX SVP, Gen Counsel & Secretary · ETNB Chief Operating Officer · APGN President and COO
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ETNB 89bio, Inc. | D To issuer deriv | 2025-10-30 | 2025-10-30 | 215,000 | — | $0 | 0 | SEC↗ |
| ETNB 89bio, Inc. | D To issuer deriv | 2025-10-30 | 2025-10-30 | 350,000 | — | $0 | 0 | SEC↗ |
| ETNB 89bio, Inc. | U Tender | 2025-10-30 | 2025-10-30 | 75,310 | — | $0 | 0 | SEC↗ |
| ETNB 89bio, Inc. | F Tax w/h | 2025-08-05 | 2025-08-05 | 2,979 | $9.69 | $28.9K | 74,231 | SEC↗ |
| ETNB 89bio, Inc. | F Tax w/h | 2025-08-01 | 2025-08-05 | 3,206 | $9.16 | $29.4K | 77,210 | SEC↗ |
| ETNB 89bio, Inc. | A Award deriv | 2025-02-01 | 2025-02-04 | 215,000 | — | $0 | 215,000 | SEC↗ |
| ETNB 89bio, Inc. | A Award | 2025-02-01 | 2025-02-04 | 53,750 | — | $0 | 78,750 | SEC↗ |
| ETNB 89bio, Inc. | A Award deriv | 2024-08-05 | 2024-08-07 | 350,000 | — | $0 | 350,000 | SEC↗ |
| ETNB 89bio, Inc. | A Award | 2024-08-05 | 2024-08-07 | 25,000 | — | $0 | 25,000 | SEC↗ |
| APGN Apexigen, Inc. | D To issuer deriv | 2023-08-23 | 2023-08-25 | 269,847 | — | $0 | 0 | SEC↗ |
| APGN Apexigen, Inc. | D To issuer | 2023-08-23 | 2023-08-25 | 124,296 | — | $0 | 0 | SEC↗ |
| APGN Apexigen, Inc. | F Tax w/h | 2023-08-23 | 2023-08-25 | 31,123 | $0.39 | $12.1K | 124,296 | SEC↗ |
| APGN Apexigen, Inc. | F Tax w/h | 2023-06-15 | 2023-06-23 | 6,917 | $0.49 | $3.4K | 155,419 | SEC↗ |
| APGN Apexigen, Inc. | A Award | 2023-05-23 | 2023-05-25 | 150,000 | — | $0 | 183,084 | SEC↗ |
| APGN Apexigen, Inc. | F Tax w/h | 2023-05-23 | 2023-05-25 | 20,748 | $0.40 | $8.3K | 162,336 | SEC↗ |
| APGN Apexigen, Inc. | F Tax w/h | 2022-12-15 | 2022-12-19 | 6,916 | $1.06 | $7.3K | 33,084 | SEC↗ |
| APGN Apexigen, Inc. | A Award | 2022-10-07 | 2022-10-11 | 40,000 | — | $0 | 40,000 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS, I | D To issuer deriv | 2021-04-16 | 2021-04-19 | 90,000 | — | $0 | 0 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS, I | D To issuer deriv | 2021-04-16 | 2021-04-19 | 90,000 | — | $0 | 0 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS, I | D To issuer deriv | 2021-04-16 | 2021-04-19 | 58,000 | — | $0 | 0 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS, I | D To issuer deriv | 2021-04-16 | 2021-04-19 | 45,000 | — | $0 | 0 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS, I | D To issuer deriv | 2021-04-16 | 2021-04-19 | 75,000 | — | $0 | 0 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS, I | D To issuer deriv | 2021-04-16 | 2021-04-19 | 25,521 | — | $0 | 0 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS, I | D To issuer deriv | 2021-04-16 | 2021-04-19 | 3,209 | — | $0 | 0 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS, I | D To issuer deriv | 2021-04-16 | 2021-04-19 | 4,747 | — | $0 | 0 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS, I | D To issuer deriv | 2021-04-16 | 2021-04-19 | 9,142 | — | $0 | 0 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS, I | D To issuer deriv | 2021-04-16 | 2021-04-19 | 12,063 | — | $0 | 0 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS, I | D To issuer | 2021-04-16 | 2021-04-19 | 795 | $38.00 | $30.2K | 0 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS, I | D To issuer | 2021-04-16 | 2021-04-19 | 795 | $38.00 | $30.2K | 0 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS, I | D To issuer | 2021-04-16 | 2021-04-19 | 795 | $38.00 | $30.2K | 0 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS, I | D To issuer | 2021-04-16 | 2021-04-19 | 169,468 | $38.00 | $6.44M | 0 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS, I | A Award | 2021-04-16 | 2021-04-19 | 66,000 | — | $0 | 169,468 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS, I | G Gift | 2021-04-06 | 2021-04-19 | 14,174 | — | $0 | 103,468 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS, I | G Gift | 2021-04-05 | 2021-04-19 | 2,460 | — | $0 | 117,642 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS, I | G Gift | 2021-04-01 | 2021-04-19 | 2,385 | — | $0 | 121,542 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS, I | G Gift | 2021-04-01 | 2021-04-19 | 1,440 | — | $0 | 120,102 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS, I | G Gift | 2021-04-01 | 2021-04-19 | 795 | — | $0 | 795 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS, I | G Gift | 2021-04-01 | 2021-04-19 | 795 | — | $0 | 795 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS, I | G Gift | 2021-04-01 | 2021-04-19 | 795 | — | $0 | 795 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS, I | F Tax w/h | 2021-02-26 | 2021-03-02 | 1,158 | $22.23 | $25.7K | 123,433 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS, I | F Tax w/h | 2021-02-25 | 2021-02-26 | 1,653 | $23.08 | $38.2K | 124,591 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS, I | F Tax w/h | 2021-02-24 | 2021-02-26 | 5,100 | $25.71 | $131.1K | 126,244 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS, I | M Exercise deriv | 2020-12-11 | 2020-12-15 | 22,000 | — | $0 | 0 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS, I | M Exercise | 2020-12-11 | 2020-12-15 | 22,000 | — | $0 | 138,010 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS, I | F Tax w/h | 2020-12-11 | 2020-12-15 | 11,583 | $16.14 | $186.9K | 126,427 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS, I | M Exercise deriv | 2020-11-11 | 2020-11-13 | 22,000 | — | $0 | 22,000 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS, I | F Tax w/h | 2020-11-11 | 2020-11-13 | 11,001 | $18.00 | $198.0K | 116,010 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS, I | M Exercise | 2020-11-11 | 2020-11-13 | 22,000 | — | $0 | 127,011 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS, I | F Tax w/h | 2020-02-26 | 2020-02-26 | 1,304 | $4.83 | $6.3K | 105,011 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS, I | F Tax w/h | 2020-02-25 | 2020-02-26 | 1,863 | $4.87 | $9.1K | 106,315 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS, I | A Award deriv | 2020-02-24 | 2020-02-26 | 90,000 | — | $0 | 90,000 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS, I | A Award deriv | 2020-02-24 | 2020-02-26 | 90,000 | — | $0 | 90,000 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS, I | A Award | 2020-02-24 | 2020-02-26 | 15,000 | — | $0 | 108,178 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS, I | A Award | 2020-02-24 | 2020-02-26 | 15,000 | — | $0 | 93,178 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS, I | F Tax w/h | 2020-02-05 | 2020-02-06 | 4,070 | $5.13 | $20.9K | 78,178 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS, I | F Tax w/h | 2019-09-01 | 2019-09-04 | 2,811 | $5.43 | $15.3K | 82,248 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | A Award deriv | 2019-06-24 | 2019-06-26 | 44,000 | — | $0 | 44,000 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | F Tax w/h | 2019-02-26 | 2019-02-27 | 1,194 | $11.95 | $14.3K | 82,955 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | A Award deriv | 2019-02-25 | 2019-02-27 | 58,000 | — | $0 | 58,000 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | A Award | 2019-02-25 | 2019-02-27 | 10,000 | — | $0 | 84,149 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | F Tax w/h | 2019-02-05 | 2019-02-07 | 2,996 | $11.43 | $34.2K | 74,149 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | F Tax w/h | 2018-09-28 | 2018-10-02 | 954 | $13.92 | $13.3K | 77,145 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | A Award | 2018-09-28 | 2018-10-02 | 1,923 | — | $0 | 78,099 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | F Tax w/h | 2018-09-01 | 2018-09-05 | 2,810 | $14.00 | $39.3K | 76,177 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | A Award deriv | 2018-02-26 | 2018-02-28 | 45,000 | — | $0 | 45,000 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | A Award | 2018-02-26 | 2018-02-28 | 7,000 | — | $0 | 78,987 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | F Tax w/h | 2017-03-01 | 2017-09-07 | 3,131 | $34.34 | $107.5K | 71,987 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | F Tax w/h | 2017-03-01 | 2017-03-03 | 19,784 | $44.77 | $885.7K | 75,118 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | A Award deriv | 2017-02-07 | 2017-02-09 | 45,000 | — | $0 | 45,000 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | A Award | 2017-02-07 | 2017-02-09 | 5,768 | — | $0 | 94,902 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | A Award | 2017-02-07 | 2017-02-09 | 10,310 | — | $0 | 89,134 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | M Exercise deriv | 2017-01-18 | 2017-01-18 | 3,636 | — | $0 | 9,142 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | M Exercise | 2017-01-18 | 2017-01-18 | 3,636 | $5.54 | $20.1K | 82,460 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | S Sale | 2017-01-18 | 2017-01-18 | 3,636 | $47.39 | $172.3K | 78,824 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | F Tax w/h | 2017-01-03 | 2017-01-05 | 2,442 | $48.60 | $118.7K | 78,824 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | M Exercise deriv | 2016-11-28 | 2016-11-30 | 1,710 | — | $0 | 12,778 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | S Sale | 2016-11-28 | 2016-11-30 | 1,710 | $60.14 | $102.8K | 81,266 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | M Exercise | 2016-11-28 | 2016-11-30 | 1,710 | $5.54 | $9.5K | 82,976 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | M Exercise deriv | 2016-11-25 | 2016-11-28 | 10,264 | — | $0 | 14,488 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | M Exercise deriv | 2016-11-25 | 2016-11-28 | 10,925 | — | $0 | 0 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | M Exercise | 2016-11-25 | 2016-11-28 | 10,925 | $6.89 | $75.3K | 92,191 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | M Exercise | 2016-11-25 | 2016-11-28 | 10,264 | $5.54 | $56.9K | 102,455 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | S Sale | 2016-11-25 | 2016-11-28 | 21,189 | $60.48 | $1.28M | 81,266 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | M Exercise deriv | 2016-11-23 | 2016-11-28 | 13,465 | — | $0 | 10,925 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | M Exercise | 2016-11-23 | 2016-11-28 | 13,465 | $6.89 | $92.8K | 94,731 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | S Sale | 2016-11-23 | 2016-11-28 | 13,465 | $60.23 | $811.0K | 81,266 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | A Award deriv | 2016-09-08 | 2016-09-12 | 35,000 | — | $0 | 35,000 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | A Award | 2016-09-08 | 2016-09-12 | 7,000 | — | $0 | 81,266 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | F Tax w/h | 2016-09-01 | 2016-09-01 | 19,568 | $44.74 | $875.5K | 74,266 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | A Award deriv | 2016-08-25 | 2016-08-29 | 60,000 | — | $0 | 60,000 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | A Award | 2016-08-25 | 2016-08-29 | 10,000 | — | $0 | 93,834 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | M Exercise deriv | 2016-03-30 | 2016-03-31 | 5,550 | — | $0 | 4,747 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | M Exercise | 2016-03-30 | 2016-03-31 | 5,550 | $8.49 | $47.1K | 89,384 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | S Sale | 2016-03-30 | 2016-03-31 | 5,550 | $40.01 | $222.1K | 83,834 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | M Exercise deriv | 2016-03-29 | 2016-03-31 | 926 | — | $0 | 0 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | M Exercise deriv | 2016-03-29 | 2016-03-31 | 3,524 | — | $0 | 10,297 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | S Sale | 2016-03-29 | 2016-03-31 | 4,450 | $40.00 | $178.0K | 83,834 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | M Exercise | 2016-03-29 | 2016-03-31 | 4,450 | $8.49 | $37.8K | 88,284 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | M Exercise deriv | 2016-01-27 | 2016-01-29 | 3,791 | — | $0 | 3,209 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | M Exercise deriv | 2016-01-27 | 2016-01-29 | 1,513 | — | $0 | 926 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | M Exercise deriv | 2016-01-27 | 2016-01-29 | 7,768 | — | $0 | 24,752 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | M Exercise deriv | 2016-01-27 | 2016-01-29 | 7,449 | — | $0 | 12,063 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | M Exercise deriv | 2016-01-27 | 2016-01-29 | 9,479 | — | $0 | 25,521 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | M Exercise | 2016-01-27 | 2016-01-29 | 7,449 | $7.26 | $54.1K | 91,019 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | M Exercise | 2016-01-27 | 2016-01-29 | 9,479 | $11.14 | $105.6K | 93,049 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | S Sale | 2016-01-27 | 2016-01-29 | 6,895 | $35.55 | $245.1K | 86,154 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | S Sale | 2016-01-27 | 2016-01-29 | 2,584 | $36.13 | $93.4K | 83,570 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | M Exercise | 2016-01-27 | 2016-01-29 | 3,791 | $10.77 | $40.8K | 87,361 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | S Sale | 2016-01-27 | 2016-01-29 | 3,791 | $35.31 | $133.9K | 83,570 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | S Sale | 2016-01-27 | 2016-01-29 | 7,449 | $35.11 | $261.5K | 83,570 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | M Exercise | 2016-01-27 | 2016-01-29 | 7,768 | $5.54 | $43.0K | 91,338 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | S Sale | 2016-01-27 | 2016-01-29 | 7,768 | $34.73 | $269.8K | 83,570 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | M Exercise | 2016-01-27 | 2016-01-29 | 1,513 | $8.49 | $12.8K | 85,083 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | S Sale | 2016-01-27 | 2016-01-29 | 1,513 | $35.00 | $53.0K | 83,570 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | A Award | 2015-08-20 | 2015-08-21 | 75,000 | — | $0 | 83,570 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | A Award deriv | 2015-08-17 | 2015-08-19 | 75,000 | — | $0 | 75,000 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | A Award | 2015-04-30 | 2015-05-04 | 6,110 | — | $0 | 8,570 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | A Award deriv | 2014-08-22 | 2014-08-26 | 35,000 | — | $0 | 35,000 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | A Award deriv | 2013-11-05 | 2013-11-07 | 7,000 | — | $0 | 7,000 | SEC↗ |